Home » Topics » BioWorld Science

BioWorld Science
RSS

Axiom, Zaiya and Nippon Kagaku anticancer drug discovery alliance

Nov. 25, 1997

Techniclone reacquires rights to Oncolym

Nov. 25, 1997

Toray/Daiichi to begin clinical development of non-narcotic analgesic

Nov. 25, 1997

Cytokine combination demonstrates antiinfective activity in mice

Nov. 25, 1997

HMR and Scriptgen enter antifungal drug discovery alliance

Nov. 25, 1997

OraVax: Q3 1997 highlights

Nov. 25, 1997

Novartis: Q3 1997 highlights

Nov. 25, 1997

GelTex: Q3 1997 highlights

Nov. 25, 1997

GalaGen: Q3 1997 highlights

Nov. 25, 1997

Draxis Health: Q3 1997 highlights

Nov. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.